BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9009225)

  • 1. Purification of ADAM 10 from bovine spleen as a TNFalpha convertase.
    Lunn CA; Fan X; Dalie B; Miller K; Zavodny PJ; Narula SK; Lundell D
    FEBS Lett; 1997 Jan; 400(3):333-5. PubMed ID: 9009225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
    Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
    Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
    Moss ML; Jin SL; Milla ME; Bickett DM; Burkhart W; Carter HL; Chen WJ; Clay WC; Didsbury JR; Hassler D; Hoffman CR; Kost TA; Lambert MH; Leesnitzer MA; McCauley P; McGeehan G; Mitchell J; Moyer M; Pahel G; Rocque W; Overton LK; Schoenen F; Seaton T; Su JL; Becherer JD
    Nature; 1997 Feb; 385(6618):733-6. PubMed ID: 9034191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases.
    Rosendahl MS; Ko SC; Long DL; Brewer MT; Rosenzweig B; Hedl E; Anderson L; Pyle SM; Moreland J; Meyers MA; Kohno T; Lyons D; Lichenstein HS
    J Biol Chem; 1997 Sep; 272(39):24588-93. PubMed ID: 9305925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.
    Lammich S; Kojro E; Postina R; Gilbert S; Pfeiffer R; Jasionowski M; Haass C; Fahrenholz F
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3922-7. PubMed ID: 10097139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation hybrid mapping of human ADAM10 gene to chromosome 15.
    Yamazaki K; Mizui Y; Tanaka I
    Genomics; 1997 Oct; 45(2):457-9. PubMed ID: 9344679
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure.
    Fahrenholz F; Gilbert S; Kojro E; Lammich S; Postina R
    Ann N Y Acad Sci; 2000; 920():215-22. PubMed ID: 11193153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the tumour necrosis factor alpha-converting enzyme, TACE/ADAM17.
    Cerretti DP
    Biochem Soc Trans; 1999 Feb; 27(2):219-23. PubMed ID: 10093737
    [No Abstract]   [Full Text] [Related]  

  • 9. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
    Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
    Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.
    Althoff K; Reddy P; Voltz N; Rose-John S; Müllberg J
    Eur J Biochem; 2000 May; 267(9):2624-31. PubMed ID: 10785383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of pro-tumor necrosis factor alpha by ADAM metallopeptidase domain 17: a fluorescence-based protease assay cleaves its natural protein substrate.
    Zhang C; Zheng L; Nurnberg J; Vacari BM; Zhou J; Wang Y
    Anal Biochem; 2014 Jan; 445():14-9. PubMed ID: 24096196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial purification and characterization of a tumor necrosis factor-alpha converting activity.
    Robache-Gallea S; Bruneau JM; Robbe H; Morand V; Capdevila C; Bhatnagar N; Chouaib S; Roman-Roman S
    Eur J Immunol; 1997 May; 27(5):1275-82. PubMed ID: 9174621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase.
    Parvathy S; Karran EH; Turner AJ; Hooper NM
    FEBS Lett; 1998 Jul; 431(1):63-5. PubMed ID: 9684866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.
    Minond D; Cudic M; Bionda N; Giulianotti M; Maida L; Houghten RA; Fields GB
    J Biol Chem; 2012 Oct; 287(43):36473-87. PubMed ID: 22927435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
    Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
    J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
    Amour A; Knight CG; Webster A; Slocombe PM; Stephens PE; Knäuper V; Docherty AJ; Murphy G
    FEBS Lett; 2000 May; 473(3):275-9. PubMed ID: 10818225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site.
    Wong E; Maretzky T; Peleg Y; Blobel CP; Sagi I
    J Biol Chem; 2015 May; 290(19):12135-46. PubMed ID: 25795784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.
    Roy R; Wewer UM; Zurakowski D; Pories SE; Moses MA
    J Biol Chem; 2004 Dec; 279(49):51323-30. PubMed ID: 15381692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity.
    Roghani M; Becherer JD; Moss ML; Atherton RE; Erdjument-Bromage H; Arribas J; Blackburn RK; Weskamp G; Tempst P; Blobel CP
    J Biol Chem; 1999 Feb; 274(6):3531-40. PubMed ID: 9920899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta.
    Nelson KK; Schlöndorff J; Blobel CP
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):673-80. PubMed ID: 10527948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.